Skip to main content

CORRECTION article

Front. Oncol., 09 December 2020
Sec. Hematologic Malignancies
Volume 10 - 2020 | https://doi.org/10.3389/fonc.2020.629875

Corrigendum: Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

This article is a correction to:

  1. Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

    1. Read original article
Qingqing Zheng&#x;Qingqing Zheng1†Chuang Jiang&#x;Chuang Jiang2†Haiyan LiuHaiyan Liu1Wenge HaoWenge Hao1Pengfei WangPengfei Wang1Haiying HuangHaiying Huang1Ziping LiZiping Li1Jiabi QianJiabi Qian1Maoxiang Qian*Maoxiang Qian3*Hui Zhang*Hui Zhang1*
  • 1Department of Hematology/Oncology, Guangzhou Women and Children’s Medical Center, Guangzhou, China
  • 2Shanghai Children’s Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China
  • 3Institute of Pediatrics and Department of Hematology and Oncology, Children’s Hospital of Fudan University, the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China

A Corrigendum on
Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia

By Zheng Q, Jiang C, Liu H, Hao W, Wang P, Huang H, Li Z, Qian J, Qian M and Zhang H (2020). Front. Oncol. 10:579673. doi: 10.3389/fonc.2020.579673

In the published article, there was an error in affiliation 3. Instead of “Shanghai Key Laboratory of Medical Epigenetics, International Co-Laboratory of Medical Epigenetics and Metabolism, Department of Hematology and Oncology, Institute of Pediatrics, Institutes of Biomedical Sciences, Children’s Hospital of Fudan University, Ministry of Science and Technology, Fudan University, Shanghai, China”, it should be “Institute of Pediatrics and Department of Hematology and Oncology, Children’s Hospital of Fudan University, the Shanghai Key Laboratory of Medical Epigenetics, International Co-laboratory of Medical Epigenetics and Metabolism, Ministry of Science and Technology, Institutes of Biomedical Sciences, Fudan University, Shanghai, China”.

The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.

Keywords: acute lymphoblast leukemia, risk stratification, relapse, FOXO1, MRD—minimal residual disease

Citation: Zheng Q, Jiang C, Liu H, Hao W, Wang P, Huang H, Li Z, Qian J, Qian M and Zhang H (2020) Corrigendum: Down-Regulated FOXO1 in Refractory/Relapse Childhood B-Cell Acute Lymphoblastic Leukemia. Front. Oncol. 10:629875. doi: 10.3389/fonc.2020.629875

Received: 17 November 2020; Accepted: 17 November 2020;
Published: 09 December 2020.

Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland

Copyright © 2020 Zheng, Jiang, Liu, Hao, Wang, Huang, Li, Qian, Qian and Zhang. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

*Correspondence: Maoxiang Qian, mxqian@fudan.edu.cn; Hui Zhang, zhanghuirjh@gwcmc.org

†These authors have contributed equally to this work

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.